Homayouni Aziz, et al.
Journal of lower genital tract disease, 2014
Abstract
Objective
Bacterial vaginosis (BV) is a common cause of genital discomfort in women in reproductive ages, which causes many complications. Bacterial vaginosis is usually treated by metronidazole and clindamycin. However, this protocol does not prevent its recurrence, which is a main complaint of the patients. The number of lactobacilli in the vagina of women with BV is significantly lower than that in healthy women. Hence, efforts have been made to normalize vaginal flora by oral or vaginal administration of lactobacilli. The objective of the present study was to review clinical evidences available regarding the efficacy of probiotics in the prevention and treatment of BV.
Materials and Methods
Published randomized controlled trials were searched in PubMed, Science Direct, and the Cochrane Database between 1990 and 2011. Search terms included bacterial vaginosis, urinary tract infection, lactobacillus, and probiotics.
Results
Orally consumed probiotics are believed to ascend to the vaginal tract after they are excreted from the rectum; vaginal administration allows for direct replacement of the probiotics for unhealthy vaginal microbiota and occupation of specific adhesion sites at the epithelial surface of the urinary tract, which consequently results in maintenance of a low pH and production of antimicrobial substances like acids and hydrogen peroxide. Receiving Lactobacillus acidophilus, Lactobacillus rhamnosus GR-1, and Lactobacillus fermentum RC-14 at a dose of at least 10 CFU/day for 2 months has been shown to present the patients with better results.
Conclusions
Although the results of different studies are controversial, most studies have been in favor of the probiotics in the prevention or treatment of BV, and no adverse effects have been reported. Therefore, it may be helpful to recommend daily consumption of probiotic products to improve public health among women.
PMID: | 24299970 |
---|---|
DOI: | 10.1097/LGT.0b013e31829156ec |
Category: | Women's Health |
The best supplements with Lactobacillus Rhamnosus, Lactobacillus Fermentum or Lactobacillus Acidophilus in Women's Health category:
- Woman's Probiotic 20 Billion, 50 Veggie Caps (Now Foods) - Now Women's Probiotic has been specially formulated using three clinically tested probiotic strains to support women's health through every stage of life. It contains among others: Lactobacillus Rhamnosus, Lactobacillus Acidophilus.
Articles similar to "Effects of Probiotics on the Recurrence of Bacterial Vaginosis: A Review."
- The role of Lactobacillus Rhamnosus in Women's Health: Long-term Lactobacillus Rhamnosus BMX 54 Application to Restore a Balanced Vaginal Ecosystem: A Promising Solution Against HPV-infection. ( Over recent years, a growing interest has developed in microbiota and in the concept of maintaining a special balance between Lactobacillus and other bacteria species in order to promote women's well-being... The consistent percentage of clearance of PAP-smear abnormalities and HPV-clearance obtained in long-term treatment group has been interestingly high and encouraging. Obviously, larger and randomized studies are warranted to confirm these encouraging results, but we believe that eubiosis re-establishment is the key to tackle effectively even HPV-infection. )
- The impact of Lactobacillus Rhamnosus on Women's Health: Probiotics in the Prevention of Recurrences of Bacterial Vaginosis. (Context: Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women during their fertile years...)
- The significance of Lactobacillus Rhamnosus for Women's Health: Effect of a Yoghurt Drink Containing Lactobacillus Strains on Bacterial Vaginosis in Women - A Double-Blind, Randomised, Controlled Clinical Pilot Trial. (Bacterial vaginosis (BV) is characterised by a depletion of lactobacilli in favour of an overgrowth of anaerobic bacteria...)
- The role of Lactobacillus Acidophilus in Women's Health: Effects of Lactobacillus Rhamnosus and Lactobacillus Acidophilus on Bacterial Vaginal Pathogens. (The human vagina is colonized by a variety of microbes...)
- The impact of Lactobacillus Rhamnosus on Women's Health: Restoring Vaginal Microbiota: Biological Control of Bacterial Vaginosis. A Prospective Case-Control Study Using Lactobacillus Rhamnosus BMX 54 as Adjuvant Treatment Against Bacterial Vaginosis. (Purpose: Bacterial vaginosis (BV) is the most prevalent lower genital tract infection in reproductive-age women worldwide... Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients. )
- The impact of Lactobacillus Acidophilus on Women's Health: Evidence-based Mixture Containing Lactobacillus Strains and Lactoferrin to Prevent Recurrent Bacterial Vaginosis: A Double Blind, Placebo Controlled, Randomised Clinical Trial. (Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women... Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients. )
- The role of Lactobacillus Rhamnosus in Women's Health: Effectiveness of Vaginal Administration of Lactobacillus Rhamnosus Following Conventional Metronidazole Therapy: How to Lower the Rate of Bacterial Vaginosis Recurrences. (Eighty-four patients with bacterial vaginosis diagnosed according to Amsel's criteria were randomized to receive either oral metronidazole 500 mg twice a day for seven days, or one vaginal tablet containing freeze-dried Lactobacillus rhamnosus once a week at bedtime for two months starting one week after the last antibiotic administration... Probiotic supplementation with vaginal Lactobacillus rhamnosus BMX54 seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of BV, in particular in high-risk patients. )